Valeritas insulin delivery device gets a name

The medical technology company's device is the first to use the h-Patch technology platform which utilises a small adhesive machine-like patch to deliver both basal and bolus insulin dosages. "We are excited to introduce V-Go as the name for our lead product, and are working to make it available for patients with diabetes in the coming year,"​ Valeritas marketing and marketing operations vice president Tara Charvat said. "V-Go was designed to mimic the physiologic distribution of insulin in a simple fashion, and we believe it has the potential to create a new standard for insulin delivery and improve patient care." ​ V-Go is a once-daily, disposable, waterproof device that provides a continuous set basal rate and on-demand bolus dosing for meal-time coverage, via a rapid acting insulin analogue, for people suffering from Type II diabetes. The patch device works by peeling a protective layer from an adhesive backing on the device and applying it to the body such as around the abdomen area. With the push of the start button, a micro-needle is inserted into the skin and supplies a basal flow of insulin. During mealtimes, the patient pushes the bolus button and a bolus dosing is administered. On removal of the device, the micro-needle retracts, limiting the needle injury risk. Developed to help enhance a patient's glycemic control and improve compliance, V-Go is the smallest known US Food and Drug Administration-cleared insulin delivery device with basal and bolus capability and no visible needle. V-Go is currently in Phase IV clinical trials to support broad marketing and reimbursement claims. The h-Patch technology is hoped to be used for the delivery of a variety of other medicinal compounds other than insulin. Other drug delivery devices Valeritas is developing include: the e-Patch Controlled Release Disposable Micro Pump System, a micro-infusion system designed to deliver drugs continuously into subcutaneous tissue; the Mini-Jet Pre-Filled Needle-Free Delivery System, a next-generation needle-free injection system; and the Micro-Trans Microneedle Transdermal Delivery Patch.